In animal and human experiments, researchers found that total parenteral nutrition reduces the level of tryptophan metabolites by changing the composition of the gut microbiota, thereby inhibiting the indole/Aryl hydrocarbon receptor (AhR) signaling pathway and the production of Glucagon-like peptide 1 (GLP-1), thus leading to glucose metabolism disorders (40). Here, AHR is linked to glucose metabolism disease.